glucose utilization — TargetMol Chemicals

Cat No.	Product Name	Synonyms	Targets
T1137	Clorsulon	L631529,MK401	ATPase , Antibiotic , Parasite
	Clorsulon (L631529) is utilized for the treatment of Fasciola hepatica infections in calves and sheep.		ATPase , Antibiotic , Parasite
T19211	BM152054		Others
	BM152054 is a potent PPARγ ligand that induces glucose utilization in peripheral tissues by enhancing insulin action.		Others
T2608	CHIR-98014	CHIR 98014,CT98014,CHIR98014	FGFR , GSK-3 , Src , S6 Kinase
	CHIR-98014 (CT98014) is a selective GSK3 inhibitor; potentiate insulin activation of glucose transport and utilization in vitro and in vivo.		FGFR , GSK-3 , Src , S6 Kinase
T0988	Trimetazidine dihydrochloride	Yoshimilon,Kyurinett,Vastarel F	Autophagy , Fatty Acid Synthase
	Trimetazidine dihydrochloride (Vastarel F) can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in isch...		Autophagy , Fatty Acid Synthase
T13752	L-(+)-Arabinose		Endogenous Metabolite
	L-(+)-Arabinose selectively inhibits intestinal sucrase activity in a non-competitive manner, inhibiting glucose elevation caused by sucrose intake.		Endogenous Metabolite
T3753	Sinapinic Acid	Sinapic acid,Synapoic acid	Apoptosis , RAAS , Reactive Oxygen Species , HDAC
	Sinapinic Acid (Synapoic acid) protects the rat liver from CCl4-induced inflammation, most likely by acting as a free radical scavenger and modulator of NF-κB p65 activation and proinflammatory cytokine expression. Sinap...		Apoptosis , RAAS , Reactive Oxygen Species , HDAC
T27324	FK614	FK 614,ATx-08-001,ATx-08001,FK-614
	FK-614 is a selective agonist of peroxisome proliferator-activated receptor gamma. FK-614 improves peripheral glucose utilization while decreases hepatic insulin extraction in alloxan-induced diabetic dogs.
T10940	D-Mannoheptulose		Others
	D-mannoheptose is the main non-structural carbohydrate in avocado. D-mannoheptose is a specific inhibitor of D-glucose phosphorylation. D-mannoheptose can prevent the release of insulin and the utilization of carbohydrat...		Others
T38674	YGsy2p-IN-H23	yGsy2p-IN-H23
	yGsy2p-IN-H23 is a potent, first-in-class inhibitor specifically designed to target yeast glycogen synthase 2 (yGsy2p). It demonstrates an IC50 value of 875 μM for human glycogen synthase 1 (hGYS1). This compound binds p...
T35839	3-Iodothyronamine (hydrochloride)
	3-Iodothyronamine is derived from the deiodination and decarboxylation of endogenous thyroxine. It activates the G protein-coupled receptor known as trace amine-associated receptor 1 at nanomolar concentrations whereupon...
T69622	Ritivixibat
	Ritivixibat is an ileal bile acid transporter (IBAT) inhibitor and bile acid modulator. It is utilized in research related to cardiovascular diseases, fatty acid metabolism disorders, glucose utilization abnormalities, g...
T37577	Glycogen Phosphorylase Inhibitor
	Glycogen phosphorylase in the liver, muscle, and brain initiate glycogenolysis by releasing glucose-1-phosphate from glycogen. Glycogen phosphorylase inhibitor is a cell-permeable acyl urea first identified as an inhibit...